Search results

  1. forestglip

    Functional characterisation of CD8+ T cells mobilised with acute supramaximal high-intensity interval exercise [...], 2025, Strömberg et al

    Functional characterisation of CD8+ T cells mobilised with acute supramaximal high-intensity interval exercise: implications for immune surveillance Anna Strömberg, Mirko Mandić, Brennan J Wadsworth, Sebastian Proschinger, Seher Alam, Lisa MJ Eriksson, Laura Barbieri, Eric Rullman, Helene...
  2. forestglip

    Dysregulated monocyte compartment in PACS patients, 2025, Kronstein-Wiedemann et al

    Dysregulated monocyte compartment in PACS patients Romy Kronstein-Wiedemann, Madeleine Teichert, Elisa Michel, Janina Berg, George Robinson, Kristin Tausche, Martin Kolditz, Johannes Bergleiter, Jessica Thiel, Dirk Koschel, Stephan R. Künzel, Kristina Hlig, Torsten Tonn, Manuela Rossol...
  3. forestglip

    [Retracted] Causal Relationship Between Diet, Lipids, Immune Cells, and [CFS]: A Two-Mediation Mendelian Randomization Study, 2025, Li et al

    I don't think "influencing" necessarily means increasing risk. They worded it differently in the paper:
  4. forestglip

    [Retracted] Causal Relationship Between Diet, Lipids, Immune Cells, and [CFS]: A Two-Mediation Mendelian Randomization Study, 2025, Li et al

    Data sources 7363 is a lot of samples. I'm also curious where they're from. I'm not sure what IEU is. Maybe this: https://gwas.mrcieu.ac.uk/
  5. forestglip

    [Retracted] Causal Relationship Between Diet, Lipids, Immune Cells, and [CFS]: A Two-Mediation Mendelian Randomization Study, 2025, Li et al

    Could you quote where they said these increase risk? They seem to consistently say cheese reduced risk of ME/CFS, except strangely in one spot they say: I don't see any data about total vs. fermented. The tables only refer to "cheese consumption".
  6. forestglip

    [Retracted] Causal Relationship Between Diet, Lipids, Immune Cells, and [CFS]: A Two-Mediation Mendelian Randomization Study, 2025, Li et al

    Interesting that NK cells and CD38+ B cells popped up. Maybe some connection to daratumumab, which kills CD38 cells and apparently helped with ME/CFS symptoms, but only in those with high enough NK cell count.
  7. forestglip

    [Retracted] Causal Relationship Between Diet, Lipids, Immune Cells, and [CFS]: A Two-Mediation Mendelian Randomization Study, 2025, Li et al

    This article has been retracted, see post #31. ---------------------------------------------------------- Causal Relationship Between Diet, Lipids, Immune Cells, and Chronic Fatigue Syndrome: A Two-Mediation Mendelian Randomization Study Jixu Li, Qi Qin, Yiran Zhu, Yulu Qian, Jialu Yin, Xin...
  8. forestglip

    2025: The 2019/24 Cochrane Larun review Exercise Therapy for CFS - including IAG, campaign, petition, comments and articles

    Really? She couldn't figure out whether or not Hilda was talking about the definition of ME/CFS changing? It might have made sense to look at the IOM report that Hilda cited, the subtitle of which is "Redefining an Illness". If the review is about "chronic fatigue" in general, she doesn't...
  9. forestglip

    2025: The 2019/24 Cochrane Larun review Exercise Therapy for CFS - including IAG, campaign, petition, comments and articles

    Again missed the point. She's saying the Cochraine review is out of date because newer studies have more evidence on harms, not that the review didn't adequately assess harms in the studies it looked at.
  10. forestglip

    2025: The 2019/24 Cochrane Larun review Exercise Therapy for CFS - including IAG, campaign, petition, comments and articles

    - https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003200.pub9/detailed-comment/en?messageId=457323262
  11. forestglip

    2025: The 2019/24 Cochrane Larun review Exercise Therapy for CFS - including IAG, campaign, petition, comments and articles

    They seem to have not understood her point. They are the ones that mentioned NICE in their paper, and she's pointing out that they mentioned the old one that agrees with their conclusions instead of the new one that does not.
  12. forestglip

    Daratumumab, isatuximab (CD38 drugs)

    Collecting all the threads we have about daratumumab: ME/CFS Patent: Method for the treatment of CFS using an inhibitory or cytotoxic agent against plasma cells, 2021, Fluge, Mella [Protocol] 2022 Pilot study in Norway - Daratumumab in ME/CFS [Protocol] Norway: Study of Daratumumab Injections...
  13. forestglip

    The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy, Korst et al. 2025

    Similarly: NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple Myeloma (2023, HemaSphere)
  14. forestglip

    Common and rare variant analyses implicate late-infancy cerebellar development and immune genes in ADHD, 2025, Zhong et al

    Common and rare variant analyses implicate late-infancy cerebellar development and immune genes in ADHD Yuanxin Zhong, Larry W. Baum, Justin D. Tubbs, Rui Ye, Lu Hua Chen, Tian Wu, Se-Fong Hung, Chun-Pan Tang, Ting-Pong Ho, Robert Moyzis, James Swanson, Chi-Chiu Lee, Pak C. Sham & Patrick W. L...
  15. forestglip

    Characterising Postural Orthostatic Tachycardia Syndrome (POTS) triggered by a viral illness compared to concussion or trauma, 2025, Wilson et al

    Characterising Postural Orthostatic Tachycardia Syndrome (POTS) triggered by a viral illness compared to concussion or trauma Gemma Wilson, Marie-Claire Seeley, Pauline Slater, Dennis H. Lau, Celine Gallagher [Letter to the editor] Link (Clinical Autonomic Research) [Paywall] No abstract...
  16. forestglip

    [68Ga]FAPI PET/CT reveals increased pulmonary fibroblast activation protein expression in long COVID patients after ICU discharge, 2025, Leer et al

    [68Ga]FAPI PET/CT reveals increased pulmonary fibroblast activation protein expression in long COVID patients after ICU discharge B. van Leer, M. Londema, Ö. Kasalak, J. H. van Snick, M. L. Duiverman, J. C. Kuijvenhoven, M. D. de Kruif, D. E. Oprea-Lager, K. Pabst, M. E. Hellemons, H. H...
  17. forestglip

    The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy, Korst et al. 2025

    Nice find. From daratumumab for ME/CFS: Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al Plot of baseline NK count vs improvement from video posted here.
  18. forestglip

    Closed RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine

    Is it placebo effect or people just naturally improving early in the illness?
Back
Top Bottom